Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Nutralife Biosciences Inc (NLBS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,893
  • Shares Outstanding, K 131,514
  • Annual Sales, $ 3,710 K
  • Annual Income, $ -2,070 K
  • 60-Month Beta -1.76
  • Price/Sales 8.50
  • Price/Cash Flow N/A
  • Price/Book 11.74
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/28/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1800 +25.00%
on 04/23/19
0.2900 -22.41%
on 05/03/19
+0.0450 (+25.00%)
since 04/22/19
3-Month
0.1000 +125.00%
on 03/07/19
0.2900 -22.41%
on 05/03/19
+0.0350 (+18.42%)
since 02/22/19
52-Week
0.1000 +125.00%
on 03/07/19
0.3400 -33.82%
on 08/27/18
-0.0100 (-4.26%)
since 05/22/18

Most Recent Stories

More News
Consumer Access to CBD Products Grows as National Retailers Stock Shelves

After the U.S. Farm Bill passed, CBD-based products have sprung up across the entire country. U.S. President Donald Trump signed the bill into effect in late 2018 after witnessing immense support pouring...

IVITF : 0.3846 (-1.33%)
SPRWF : 1.3900 (-1.63%)
IGC : 1.12 (+3.70%)
GENE.VN : 0.520 (unch)
FIRE.TO : 1.86 (-1.06%)
TRTC : 0.7400 (-3.27%)
NLBS : 0.2250 (-4.21%)
Exclusive Agreement Between NutraLife Biosciences Inc. and Owen J. Morgan Introduces Breakthrough Hemp Crop Extraction Technologies

Coconut Creek, Florida--(Newsfile Corp. - May 14, 2019) - NutraLife Biosciences, Inc. (OTCQB: NLBS) (the "Company" or "NutraLife") announces that its subsidiary, PhytoChem Technologies, Inc. ("PhytoChem"),...

GLEC : 0.0007 (-56.25%)
NLBS : 0.2250 (-4.21%)
Exclusive Agreement Between NutraLife Biosciences Inc. (NLBS) and Owen J. Morgan Introduces Breakthrough Hemp Crop Extraction Technologies

via NEWMEDIAWIRE -- NutraLife Biosciences, Inc. (the "Company" or "NutraLife") (OTCQB: NLBS) announces that its subsidiary, PhytoChem Technologies, Inc. ("PhytoChem") has entered an exclusive agreement...

GLEC : 0.0007 (-56.25%)
NLBS : 0.2250 (-4.21%)
Numerous Factors Combine to Propel the CBD and Cannabis Market Forward

Centuries ago, cannabis was widely used in ancient Indian, Chinese, Egyptian, and Islamic cultures for medicinal purposes. However, the Single Convention on Narcotic Drugs deemed cannabis as an illegal...

SRNE : 3.65 (+1.39%)
CWBHF : 15.5400 (unch)
CWEB.CN : 20.950 (+0.72%)
NLBS : 0.2250 (-4.21%)
ZYNE : 14.66 (-1.08%)
PBIO : 3.0600 (-0.97%)
TGOD.TO : 4.21 (+2.93%)
TGODF : 3.1500 (+3.00%)
CBD Empowers Users to Receive Therapeutic Benefits Without the High

Following the rise of the cannabis industry, many consumers around the U.S. have heard of at least one of its derivatives: CBD. CBD, or cannabidiol, is a non-addictive compound found in the resinous flower...

GTII.CN : 15.440 (-3.56%)
MRMD : 3.0850 (-1.66%)
NLBS : 0.2250 (-4.21%)
ACRGF : 19.2500 (+4.99%)
NEPT.TO : 5.55 (+3.16%)
PBIO : 3.0600 (-0.97%)
GTBIF : 11.5290 (-3.56%)
ACRG-U.CN : 19.260 (+5.02%)
NEPT : 4.16 (+3.48%)
Leading Global Powers Back CBD for Medical Applications

Dozens of countries across the world have moved to legalize cannabis in some form, even though the majority of these countries are only allowing cannabis for medical applications. The plant is comprised...

NBEV : 5.63 (+4.84%)
CL.CN : 15.800 (+1.67%)
APHA : 6.74 (-1.32%)
CRLBF : 11.7800 (+1.16%)
NLBS : 0.2250 (-4.21%)
TRST.TO : 7.94 (+0.76%)
APHA.TO : 9.03 (-1.42%)
PBIO : 3.0600 (-0.97%)
CTST : 5.90 (+0.34%)
Widespread Clinical Studies Can Reinvigorate the Legalization Movement for Cannabis

Researchers and scientists are constantly developing new, innovative medicines to effectively treat patients. However, the cost to conduct clinical trials and then receive approval to commercialize a drug...

SRNE : 3.65 (+1.39%)
NTEC : 5.13 (+4.06%)
NLBS : 0.2250 (-4.21%)
ZYNE : 14.66 (-1.08%)
NEPT.TO : 5.55 (+3.16%)
PBIO : 3.0600 (-0.97%)
NEPT : 4.16 (+3.48%)
Regulatory Bodies Reinforce Credibility of Cannabis' Medical Applications

Hemp, a derivative of the cannabis plant, has been used for centuries due to its multi-faceted nature. Hemp, for instance, is used to manufacture textiles, paper, construction materials, and fuel. Most...

IMLFF : 0.3200 (-1.14%)
SCQBD : 0.7420 (+1.08%)
LHSIF : 0.5600 (+2.75%)
POTND : 0.0200 (+32.45%)
LBUY : 1.0600 (-1.85%)
NLBS : 0.2250 (-4.21%)
LHS.CN : 0.740 (unch)
NutraLife Biosciences (NLBS) Announces New Phytocannabinoid Rich (PCR Pure) Water Enhancing Product Line

via NEWMEDIAWIRE -- NutraLife Biosciences, Inc. (the "Company" or "NutraLife") (OTCQB: NLBS) to launch a new line of Phytocannabinoid rich (PCR) water enhancing drops under its new in-house brand PCR Pure....

NLBS : 0.2250 (-4.21%)
Update: NutraLife Biosciences, Inc. Enters into Joint Venture with Henning Trading LLC to Cultivate and Process Hemp for 2019 U.S. Grow Season

via NEWMEDIAWIRE -- NutraLife Biosciences, Inc. (the "Company" or "NutraLife") (OTCQB: NLBS) announces that its wholly-owned subsidiary, PhytoChem Technologies, Inc. ("PhytoChem") has entered into a joint...

NLBS : 0.2250 (-4.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade NLBS with:

Key Turning Points

2nd Resistance Point 0.2317
1st Resistance Point 0.2283
Last Price 0.2250
1st Support Level 0.2233
2nd Support Level 0.2217

See More

52-Week High 0.3400
Fibonacci 61.8% 0.2483
Last Price 0.2250
Fibonacci 50% 0.2200
Fibonacci 38.2% 0.1917
52-Week Low 0.1000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar